| Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B P Marcellin, GKK Lau, F Bonino, P Farci, S Hadziyannis, R Jin, ZM Lu, ... New England Journal of Medicine 351 (12), 1206-1217, 2004 | 1523 | 2004 |
| Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis P Skendros, A Mitsios, A Chrysanthopoulou, DC Mastellos, S Metallidis, ... The Journal of clinical investigation 130 (11), 6151-6157, 2020 | 677 | 2020 |
| Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus … D Lavillette, Y Morice, G Germanidis, P Donot, A Soulier, E Pagkalos, ... Journal of virology 79 (10), 6023-6034, 2005 | 351 | 2005 |
| Antiviral action of ribavirin in chronic hepatitis C JM Pawlotsky, H Dahari, AU Neumann, C Hezode, G Germanidis, ... Gastroenterology 126 (3), 703-714, 2004 | 328 | 2004 |
| Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B F Bonino, P Marcellin, GKK Lau, S Hadziyannis, R Jin, T Piratvisuth, ... Gut 56 (5), 699-705, 2007 | 319 | 2007 |
| The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related … VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ... Metabolism 71, 17-32, 2017 | 285 | 2017 |
| Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment F Penin, C Combet, G Germanidis, PO Frainais, G Deléage, JM Pawlotsky Journal of virology 75 (12), 5703-5710, 2001 | 275 | 2001 |
| Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations JM Pawlotsky, G Germanidis, AU Neumann, M Pellerin, PO Frainais, ... Journal of Virology 72 (4), 2795-2805, 1998 | 266 | 1998 |
| Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative … P Marcellin, GK Lau, F Bonino, P Farci, S Hadziyannis, R Jin, ZM Lu, ... N Engl J Med 351 (12), 1206-17, 2004 | 181 | 2004 |
| Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy … JM Pawlotsky, M Pellerin, M Bouvier, F Roudot‐Thoraval, G Germanidis, ... Journal of medical virology 54 (4), 256-264, 1998 | 148 | 1998 |
| Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses JL Raoul, J Bruix, TF Greten, M Sherman, V Mazzaferro, P Hilgard, ... Journal of hepatology 56 (5), 1080-1088, 2012 | 141 | 2012 |
| Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy JM Pawlotsky, G Germanidis, PO Frainais, M Bouvier, A Soulier, ... Journal of virology 73 (8), 6490-6499, 1999 | 117 | 1999 |
| Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation C HEzode, C Duvoux, G Germanidis, F Roudot-Thoraval, AL Vincens, ... Hepatology 30 (3), 775-778, 1999 | 95 | 1999 |
| Hepatitis C virus infection in patients with overt B-cell non-Hodgkin’s lymphoma in a French center G Germanidis, C Haioun, J Pourquier, P Gaulard, JM Pawlotsky, ... Blood, The Journal of the American Society of Hematology 93 (5), 1778-1779, 1999 | 95 | 1999 |
| The non‐structural 5A protein of hepatitis C virus JM Pawlotsky, G Germanidis Journal of viral hepatitis 6 (5), 343-356, 1999 | 89 | 1999 |
| Current insights into the innate immune system dysfunction in irritable bowel syndrome N Lazaridis, G Germanidis Annals of gastroenterology 31 (2), 171, 2018 | 74 | 2018 |
| HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project) M Pilli, A Zerbini, A Penna, A Orlandini, E Lukasiewicz, JM Pawlotsky, ... Gastroenterology 133 (4), 1132-1143, 2007 | 72 | 2007 |
| Tumor-associated neutrophils in hepatocellular carcinoma pathogenesis, prognosis, and therapy K Arvanitakis, I Mitroulis, G Germanidis Cancers 13 (12), 2899, 2021 | 66 | 2021 |
| Tumor-associated macrophages in hepatocellular carcinoma pathogenesis, prognosis and therapy K Arvanitakis, T Koletsa, I Mitroulis, G Germanidis Cancers 14 (1), 226, 2022 | 65 | 2022 |
| Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept G Germanidis, P Hytiroglou, M Zakalka, L Settas Journal of hepatology 56 (6), 1420-1421, 2012 | 64 | 2012 |
